A leading supplier of drug testing kits recently revealed an updated screening panel that excludes cannabis testing and places a greater emphasis on fentanyl detection. Psychemedics, a company based in Massachusetts known for manufacturing the first commercially viable hair drug test in 1986, announced on Friday the launch of a new five-panel drug screen.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…